CMTM6 and melanoma: Furthermore, in the immunotherapy context, Mezzadra et al. recently demonstrated that loss of chemokine-like factor (CKLF)-like MARVEL transmembrane domain containing family member 6 (CMTM6) decreased PD-L1 protein levels in melanoma cells [120].